HAC (Russian)
RSCI (Russian)
EBSCO
DOI (USA)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

MODERN PROBLEMS OF DIAGNOSIS AND TREATMENT FUNCTIONAL DISEASES, ACCOMPANIED BY CONSTIPATION

Download full text PDF
Issue: 
2
Year: 
2016

Professor M. Osadchuk (1), MD; Professor A. Osadchuk (2), MD 1 -I.M. Sechenov First Moscow State Medical University 2 -Samara State Medical University

Constipation is extremely urgent health problem. The prevalence of this syndrome in Russia is 20%. In the work with current recommendations presented effective schemes of diagnosis and treatment of chronic constipation, focused on various material resources.

Keywords: 
functional constipation
diagnostics
treatment



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Martin B., Barghout V., Cerulli A. Direct medical costs of constipation in the . United States // Manag. Care Interface. – 2006; 19: 43–9.
  2. Nyrop K., Palsson O., Levy R. et al. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain // Aliment. Pharmacol. Ther. – 2007; 26: 237–48.
  3. Singh G., Lingala V., Wang H. et al. Use of health care resources and cost of care for adults with constipation // Clin. Gastroenterol. Hepatol. – 2007; 5: 1053–8.
  4. World Gastroenterology Organisation Global Guidelines. Constipation: a global perspective, 2010; 13 r.
  5. Informatsija o zasedanii Ekspertnogo soveta po probleme hronicheskih zaporov // Ros. zhurn. gastroenterol. gepatol. koloproktol. – 2011; 4: 90–1.
  6. Maev I.V., Cheremushkin S.V. Sindrom razdrazhennogo kishechnika. Rimskie kriterii III // Consilium Medicum. – 2007; 1: 29–34.
  7. Minushkin O.N. Funktsional'nye rasstrojstva zheludochno-kishechnogo trakta // Consilium Medicum. – 2004; 6 (6): 376–81.
  8. Movshovich B.L., Osadchuk A.M. Zapor Obschaja vrachebnaja praktika: Nats. rukovodstvo. T. 1. Pod red. I.N. Denisova, O.M. Lesnjak / M.: GEOTAR-Media, 2013; s. 528–34.
  9. Svistunov A.A., Osadchuk, M.A., Osadchuk M.M. i dr. Sindrom razdrazhen nogo kishechnika kak problema pervichnogo zvena zdravoohranenija // Vrach. – 2014; 3: 14–8.
  10. Ivashkin V.T., Baranskaja E.K., Poluektova E.A. i dr. Klinicheskie reko mendatsii po diagnostike i lecheniju hronicheskogo zapora u vzroslyh patsien-tov / M., 2013; 19 s.
  11. Bharucha E. Constipation // Best Pract. Res. Clin. Gastroenterol. – 2007; 21 11. (4): 709–31.
  12. Singh G., Vadhavkar S., Wang H. Complications and comorbidities of constipation in adults // Gastroenterology. – 2007; 132 (2): A458.
  13. Singh G., Kahler K., Bharathi V. Constipation in adults: complications and comorbidities // Gastroenterology. – 2005; 128 (2): A154.
  14. Huang W., Wang C., Hsieh C. et al. Management of patients with stercoral perforation of the sigmoid colon: report of five cases // World J. Gastroenterol. – 2006; 12: 500–3.
  15. Drossman D. The functional gastrointestinal disoders and the Rome III process // Gastroenteology. – 2006; 130 (5): 1377–90.
  16. Lewis S., Heaton K. et al. Stool form scale as a useful guide to intestinal transit time // Scand. J. Gastroenterol. – 1997; 32: 920–4.
  17. Rao S. Constipation: Evaluation and treatment of colonic and anorectal motility disorders // Gastrointest. Endosc. Clin. N. Am. – 2009; 19: 117–319.
  18. American Gastroenterological Association Medical Position Statement on Constipation // Gastroenterology. – 2013; 144: 211–7.
  19. Ivashkin V.T., Abdulhakov S.R., Baranskaja E.K. i dr. Klinicheskie reko mendatsii Rossijskoj gastroenterologicheskoj assotsiatsii po diagnostike i lecheniju vzroslyh patsientov s hronicheskim zaporom // Ros. zhurn. gastroen-terol., gepatol., koloproktol. – 2014; 5: 69–75.
  20. Lee-Robichaud H., Thomas K., Morgan J. et al. Lactulose versus Polyethylene Glycol for Chronic Constipation // Cochrane Database Syst. Rev. – 2010; 7 (7): CD007570.
  21. Quigley E., Vandeplassche L., Kerstens R. et al. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation-a 12-week, randomized, double-blind, placebo-controlled study // Aliment. Pharmacol. Ther. – 2009; 29 (3): 315–28.
  22. Quigley E. Prucalopride: safety, efficacy and potential applications // 22. Therap. Adv. Gastroenterol. – 2012; 5 (1): 23–30.